Drug rebate agreements under an open-house procedure

Summary

The tender concerns drug rebate agreements between IKK classic and all interested and suitable pharmaceutical companies. These are non-exclusive agreements for various active substances and active substance combinations under equal, non-negotiable terms. The bidder must submit a signed contract and the required evidence and self-declarations on time so that accession can take effect on the desired date.